Sub menu

 
 

AusPAR: Amlodipine / Valsartan

Australian Public Assessment Report
AusPAR
Device/Product Name
Exforge/Ejocia 5/320 / Exforge/Ejocia 10/320
Active ingredients
Amlodipine / Valsartan
AusPAR Date
Published
Sponsor
Novartis Pharmaceuticals Australia Pty Limited
Submission Number
PM-2009-01168-3-3
Submission Type
Major variation (new strength)

How to access a pdf or Word document

*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.

Help us improve the Therapeutic Goods Administration site